Russia to register its first vaccine

category:Hot
 Russia to register its first vaccine


Why does Russian vaccine lead the world

Why Russia can develop a new coronal vaccine so quickly is a topic of great concern to the outside world. Russian health minister murashko said that after the who announced the new coronavirus pandemic, the Russian research center immediately began to develop vaccines, according to the Russian Communist Youth League Pravda 11 daily. Russian scientists use their own experience and mature technology to produce adenovirus vector vaccine. On whether there are similar vaccines registered in other countries in the world, murashko said similar studies have been conducted in China and other countries, but clinical trials are still under way. In Russia, the new vaccine showed high efficiency and safety based on clinical trials, and all volunteers produced antibodies without serious side effects.

According to Russian media, the Russian government plans to vaccinate the vaccine from occupations at risk of infection with the new coronavirus, which is expected to start at the end of August or early September. The vaccine will be available on January 1 next year. In other words, the elderly and other groups are likely to start mass vaccination next year.

The Russian Association of clinical research organizations has called on the Russian Ministry of health to put forward a proposal to postpone the national registration of the first batch of vaccines developed in Russia until the third stage of clinical trials is successfully completed, the Russian opinion reported on the 11th. At the same time, a pharmaceutical company called on the Russian Ministry of health to delay the registration of the vaccine. In response, Nikolai brico, chief non staff epidemiologist at the Russian Ministry of health, said the technology used in the vaccine had been used in the development of other vaccines, so there was no need to delay the registration of this vaccine. The vaccine of gamaliya center did not come out of thin air. The center has been working in this direction for more than ten years, developing vaccines against Ebola and other viruses. Adenovirus vector technology is also used in the development of new coronavirus vaccine, and the related technology already exists. Most importantly, the vaccine has passed the relevant research stage. These stages are very strict, more stringent than when developing drugs. In view of the emergency situation caused by the new crown outbreak, registration can be accelerated because post registration supervision helps to evaluate the long-term safety and effectiveness of vaccines.

However, there are also doubts about the safety of Russias new crown vaccine. According to US media, US Presidential Assistant Kylie Ann Conway said that there were too few clinical human trials of Russias new coronavirus vaccine, which lagged behind the progress of the United States. She said that according to the Russian announcement, this is far from the status quo of the US side. Kelly Ann Conway said that trump will listen to a briefing on the work of the new crown vaccine in the United States later on the 11th local time, and may inform the outside world of the latest progress.

Yang zhanqiu, a professor at the Institute of Virology, School of basic medicine, Wuhan University, told the global times on March 11 that China and the United States simultaneously announced the opening of clinical trials of the new coronavirus vaccine. Russia did not announce it at that time, but it can not be said that Russia is lagging behind. After the outbreak of the new crown disease, many countries have started vaccine research and development rapidly, in this regard, many countries in the world are synchronous. Generally speaking, the development cycle of one and a half years is relatively fast. It has been about eight months since January this year, and the safety and effectiveness of the vaccine can be initially solved in more than half a year. If this problem is not solved, Russia should not dare to release the news. It can only be said that Russia has accelerated the process of transition from laboratory research to commercialization.

Who spokesman Tarik yasharevitch said at a press conference on the 11th that who and the Russian government have maintained contact on the safety and efficacy evaluation of the first new coronavirus registered vaccine.

Experts: will accelerate the development of vaccines in China and the United States

(function(){( window.slotbydup=window .slotbydup||[]).push({id:u5811557,container:ssp_ 5811557, async:true }Philippine President duterte said in a televised speech to the people on November 11 that he would voluntarily become the first person to personally test Russias new coronavirus vaccine. According to reports, President Vucci of Serbia said that his country was ready to become the first country to receive Russias vaccine. Yang zhanqiu believes that Russias progress will promote vaccine development in China, the United States and even the world. Russias preemptive announcement of this news has something to do with Russia itself and the epidemic situation in Europe. Russias preemptive announcement of major progress in vaccine development will help to seize the European market. According to the latest report released by who on July 31, there are 165 vaccine candidates in the world, of which 139 are still in the pre clinical evaluation stage, and the other 26 vaccines are in different stages of human trials. Among them, 6 vaccines are ahead of schedule and enter the third phase of clinical trial. Source: Global Times Author: Liu Yupeng, Li Sikun, editor in charge: Kang Ruixin_ NB16727

Philippine President duterte said in a televised speech to the people on 11 November that he would voluntarily become the first person to personally test Russias new coronavirus vaccine. According to reports, President Vucci of Serbia said that his country was ready to become the first country to receive Russias vaccine.

According to the latest report released by who on July 31, there are 165 vaccine candidates in the world, of which 139 are still in the pre clinical evaluation stage, and the other 26 vaccines are in different stages of human trials. Among them, 6 vaccines are ahead of schedule and enter the third phase of clinical trial.